The ‘very, very bad look' of remdesivir, the first FDA-approved COVID-19 drug; FDA (Hahn & O'Day) held no advisory meeting on antiviral, and the European Union signed contract without

by Paul Alexander

knowing of failed trial (Wang et al.); President Donald Trump and Food and Drug Administration Commissioner Stephen Hahn (right) met with Daniel O'Day (left), CEO of Gilead Sciences

Hahn et al. snowed Trump, lied to him, with Fauci et al.